Skip to main content

Axsome Therapeutics, Inc.

AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001579428

In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 508 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.

Holders of 5% or more of AXSM

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Axsome Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of AXSM
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A5.30%2.74M shares–Jul 27, 20261 filingJul 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

24 Schedule 13D and 13G filings on Axsome Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on AXSM
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 27, 20264:25 PM ETBlackRock, Inc.13G/A5.30%2.74M shares–Jun 30, 2026SEC
Mar 26, 20264:11 PM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Aug 14, 20258:02 AM ETRTW Investments, LPand 1 other13G/A3.10%1.52M shares−2.90 ppfrom 6.00%Below 5%Jun 30, 2025SEC
May 15, 20258:09 AM ETRTW Investments, LPand 1 other13G/A6.00%2.92M shares−2.40 ppfrom 8.40%Mar 31, 2025SEC
Feb 14, 20259:00 AM ETRTW Investments, LPand 1 other13G/A8.40%4.05M shares–Dec 31, 2024SEC
Feb 14, 2024Fairmount Funds Management LLC13G/AOld format–––SEC
Feb 14, 2024RTW Investments, LP13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13G/AOld format–––SEC
Jan 26, 20245:25 PM ETBlackRock Inc.13G/AOld format–––SEC
Jul 7, 2023Fairmount Funds Management LLC13GOld format–––SEC
Feb 14, 2023Venrock Healthcare Capital Partners II, L.P.13G/AOld format–––SEC
Feb 14, 2023PFM Health Sciences, LP13G/AOld format–––SEC
Feb 14, 2023Fairmount Funds Management LLC13G/AOld format–––SEC
Feb 14, 2023RTW Investments, LP13GOld format–New–SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 1, 20234:54 PM ETBlackRock Inc.13G/AOld format–––SEC
Oct 26, 2022Fairmount Funds Management LLC13GOld format–New–SEC
Oct 24, 2022PFM Health Sciences, LP13GOld format–New–SEC
Feb 9, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 3, 20224:41 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 18, 2022Iridian Asset Management LLC13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13GOld format–New–SEC
Feb 4, 2021Iridian Asset Management LLC13GOld format–New–SEC
Jan 28, 20215:55 PM ETBlackRock Inc.13G/AOld format–––SEC

Form 144: proposed insider sales

69 notices from officers, directors and other affiliates planning to sell Axsome Therapeutics, Inc. shares, newest first.

Form 144 notices for AXSM
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Sep 3, 20265:43 PM ETMark JacobsonOfficer10.0K$2.08MSep 3, 202610b5-1Goldman Sachs & Co. LLCSEC
Aug 6, 20265:09 PM ETHerriot TabuteauOfficer4.66K$979.2KAug 6, 202610b5-1Goldman Sachs & Co. LLCSEC
Aug 5, 20266:04 PM ETHerriot TabuteauOfficer45.0K$9.58MAug 5, 202610b5-1Goldman Sachs & Co. LLCSEC
Jul 1, 20265:35 PM ETHerriot TabuteauOfficer49.7K$12.0MJul 1, 202610b5-1Goldman Sachs & Co. LLCSEC
Jun 11, 20265:09 PM ETJeffs RogerDirector286$71.2KJun 11, 202610b5-1Charles Schwab & Co., Inc.SEC
Jun 10, 20264:17 PM ETMahony SusanDirector300$73.9KJun 10, 202610b5-1Charles Schwab & Co., Inc.SEC
Jun 10, 20264:16 PM ETJeffs RogerDirector286$70.4KJun 10, 202610b5-1Charles Schwab & Co., Inc.SEC
Jun 10, 20264:15 PM ETColeman MarkDirector643$160.1KJun 10, 202610b5-1Charles Schwab & Co., Inc.SEC
Jun 9, 20266:01 PM ETHerriot TabuteauOfficer49.7K$12.2MJun 9, 202610b5-1Goldman Sachs & Co. LLCSEC
Jun 9, 20264:09 PM ETPizzie NickOfficer33.0K$7.92MJun 9, 202610b5-1Charles Schwab & Co., Inc.SEC
Jun 9, 20264:06 PM ETMahony SusanDirector300$71.2KJun 9, 202610b5-1Charles Schwab & Co., Inc.SEC
Jun 2, 20264:10 PM ETColeman MarkDirector5.54K$1.24MJun 2, 202610b5-1Charles Schwab & Co., Inc.SEC
Jun 1, 20264:05 PM ETColeman MarkDirector6.00K$1.38MJun 1, 202610b5-1Charles Schwab & Co., Inc.SEC
May 29, 20264:09 PM ETColeman MarkDirector6.00K$1.40MMay 29, 202610b5-1Charles Schwab & Co., Inc.SEC
May 5, 20265:55 PM ETMark JacobsonOfficer233$52.0KMay 5, 202610b5-1Goldman Sachs & Co. LLCSEC
May 5, 20265:54 PM ETAmendedMark JacobsonOfficer4.52K$1.01MMay 4, 202610b5-1Goldman Sachs & Co. LLCSEC
Apr 22, 20264:03 PM ETMaizel AriOfficer7.50K$1.37MApr 22, 202610b5-1Charles Schwab & Co., Inc.SEC
Feb 26, 20264:53 PM ETMark JacobsonOfficer35.4K$5.77MFeb 26, 202610b5-1Goldman Sachs & Co. LLCSEC
Feb 26, 20264:20 PM ETColeman MarkDirector25.0K$4.03MFeb 26, 202610b5-1Charles Schwab & Co., Inc.SEC
Feb 2, 20265:30 PM ETHerriot TabuteauOfficer32.4K$6.02MFeb 2, 202610b5-1Goldman Sachs & Co. LLCSEC
Jan 22, 20264:02 PM ETPizzie NickOfficer12.0K$2.25MJan 22, 202610b5-1Charles Schwab & Co., Inc.SEC
Jan 21, 20264:08 PM ETMaizel AriOfficer7.50K$1.38MJan 21, 202610b5-1Charles Schwab & Co., Inc.SEC
Jan 7, 20264:44 PM ETHerriot TabuteauOfficer31.3K$5.34MJan 7, 202610b5-1Goldman Sachs & Co. LLCSEC
Jan 6, 20264:58 PM ETHerriot TabuteauOfficer29.4K$5.06MJan 6, 202610b5-1Goldman Sachs & Co. LLCSEC
Jan 5, 20265:18 PM ETHerriot TabuteauOfficer78.7K$13.5MJan 5, 2026Goldman Sachs & Co. LLCSEC

Showing the latest 25. See the AXSM notices from the last 12 months